|
Researcher
|
Institution
|
Project Title
|
Duration
|
Total Funding
|
|
Prof Francis J Bowden
|
Australian National University
|
Screening for Chlamydia
trachomatis with routine Pap smears in general practice: A randomised
controlled trial
|
2005-2007
|
$350,500
|
|
A/Pr Roger J Daly
|
Garvan Institute of Medical
Research
|
Regulation of mitogenic
signalling via the Gab2 docking protein
|
2003
|
$141,750
|
|
Prof Judith M Lumley
|
La Trobe University
|
Perinatal outcomes
following treatment for cervical dysplasia
|
2003-2004
|
$98,600
|
|
A/Pr Michael A McGuckin
|
Mater Misericordiae Health
Services Brisbane Limited
|
The muc1 epithelial mucin
in breast and ovarian cancer
|
2000
|
$355,548
|
|
A/Pr Martin Pera
|
Monash University
|
Regulation Of Human
Multipotent Stem Cells By Membrane Bound And Soluble Factors
|
2000-2001
|
$344,732
|
|
A/Pr Peter AW Rogers
|
Monash University
|
Regulation of endometrial
angiogenesis and lymphangiogenesis
|
2006-2008
|
$477,750
|
|
A/Prof Peter AW Rogers
|
Monash University
|
New blood vessel growth in
the human uterus
|
2000-2004
|
$744,219
|
|
Dr Caroline E Gargett
|
Monash University
|
A study of cells
responsible for growth of the human uterus
|
2004-2006
|
$409,575
|
|
Dr Jillian M Shaw
|
Monash University
|
Development of ovarian
cryopreservation and autografting procedures
|
2000
|
$264,367
|
|
Prof David A Jans
|
Monash University
|
Regulation of nuclear
import of viral oncoproteins and transcription factors by
protein-protein interactions
|
2001-2005
|
$650,383
|
|
Prof Donald McNaughton
|
Monash University
|
Infrared spectroscopic
imaging in the diagnosis of cervical cancer
|
2003-2005
|
$291,600
|
|
A/Pr Freddy Sitas
|
NSW Cancer Council
|
The effect of exogenous
hormones, smoking and HPV on the incidence of screen detected pre-invasive
cervical cancer
|
2006-2010
|
$1,151,625
|
|
Prof Mark S Baker
|
Peter MacCallum Cancer Centre
|
Understanding ovarian
cancer metastasis
|
2000-2002
|
$166,725
|
|
Prof Peter J Fuller
|
Prince Henry's Institute of
Medical Research
|
Identification of Key Genes in
Cancer of the Ovary
|
2000-2002
|
$264,601
|
|
A/Pr Andreas Suhrbier
|
Queensland Institute of
Medical Research
|
A new function for a known
enzyme inhibitor- implications for cancer
|
2004-2006
|
$463,500
|
|
A/Pr Andreas Suhrbier
|
Queensland Institute of
Medical Research
|
The human papilloma virus
oncoprotein E7 degrades the retinoblastoma protein by enhancing calpain
activity
|
2006-2008
|
$252,500
|
|
Dr Amanda B Spurdle
|
Queensland Institute of
Medical Research
|
Functional Evaluation of
BRCA1 & BRCA2 Unclassified Sequence Variants and Identification of
Critical Pathogenic Domains
|
2003-2005
|
$331,313
|
|
Dr Amanda B Spurdle
|
Queensland Institute of
Medical Research
|
Molecular Epidemiology of
Endometrial Cancer
|
2005-2007
|
$1,473,480
|
|
Dr Georgia A Chenevix-Trench
|
Queensland Institute of
Medical Research
|
Microarray-targeted
candidate gene approach to finding ovarian cancer susceptibility genes
|
2006-2008
|
$601,250
|
|
Prof Judith Clements
|
Queensland University of Technology
|
Expression and functional
studies on the novel ovarian-expressed serine protease, Kallikrein 4, in
ovarian tumorigenesis
|
2003-2005
|
$410,250
|
|
Prof Judith Clements
|
Queensland University of Technology
|
Role of Kallikreins in
ovarian cancer progression
|
2006-2008
|
$498,750
|
|
Prof Richard Ivell
|
University of Adelaide
|
Relaxin signalling in the
endometrium and the regulation of early pregnancy
|
2005-2007
|
$466,125
|
|
A/Pr Ian G Campbell
|
University of Melbourne
|
Cloning of chromosome 22
tumour suppressor genes
|
2004-2006
|
$249,250
|
|
A/Pr Ian G Campbell
|
University of Melbourne
|
LOH in cancer associated
stroma
|
2006-2008
|
$392,500
|
|
A/Pr Ian G Campbell
|
University of Melbourne
|
Genome-wide study of loss
of heterozygosity using high density SNP arrays to identify breast cancer
predisposition genes
|
2006-2008
|
$531,250
|
|
A/Pr Wayne A Phillips
|
University of Melbourne
|
Phosphatidylinositol
3-kinase mutations associated with ovarian, colon and breast tumour
|
2004-2005
|
$154,000
|
|
A/Pr Wayne A Phillips
|
University of Melbourne
|
PI 3-kinase: a new player
in human cancer
|
2006-2008
|
$542,750
|
|
Dr Phillip K Darcy
|
University of Melbourne
|
Activation and expansion of
gene-engineered killer T cells
|
2002
|
$115,660
|
|
Dr Richard B Pearson
|
University of Melbourne
|
Biochemical analysis of Akt
3-specific signal transduction
|
2005-2007
|
$349,375
|
|
Prof David DL Bowtell
|
University of Melbourne
|
Molecular Epidemiology of
Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical
Follow-Up Core
|
2006-2010
|
$830,000
|
|
Prof David DL Bowtell
|
University of Melbourne
|
Combined expression
analysis and SNP-based measurement of copy number variation in ovarian cancer
|
2006-2008
|
$432,500
|
|
Prof Joseph F Sambrook
|
University of Melbourne
|
kConFaB - A Consortium for
research on familial breast cancer
|
2000-2002
|
$1,624,711
|
|
Prof Lenore H Manderson
|
University of Melbourne
|
Social aspects and cultural
meanings of gynaecological cancer diagnosis, treatment and adjustment of
Victorian women
|
2004-2005
|
$158,500
|
|
Dr Bettina Meiser
|
University of New South
Wales
|
A randomised trial of a
decision aid for women at increased risk for ovarian cancer
|
2002-2003
|
$115,110
|
|
Prof Robyn Ward
|
University of New South
Wales
|
Germline epimutations of
tumour suppressor genes in familial cancer
|
2005-2007
|
$502,500
|
|
Dr Germain J Fernando
|
University of Queensland
|
How to induce a long
lasting anti-tumour response
|
2000-2002
|
$242,567
|
|
Dr Germain J Fernando
|
University of Queensland
|
Optimising immunity towards
cancers by vaccination
|
2002-2004
|
$211,320
|
|
Dr Graham R Leggatt
|
University of Queensland
|
CTL avidity as a
determinant of the mature, antigen-specific immune repertoire
|
2000-2003
|
$241,528
|
|
Dr Nigel AJ McMillan
|
University of Queensland
|
The role of the human
papillomavirus in alpha-6 integrin activation and cell growth
|
2000-2001
|
$229,217
|
|
Dr Nigel AJ McMillan
|
University of Queensland
|
NHPV and cervical
carcinoma: Signalling and clinical responses to interferons
|
2002-2004
|
$534,480
|
|
Dr Nigel AJ McMillan
|
University of Queensland
|
Treatment of
virally-induced cancers by RNA Interference
|
2004-2006
|
$389,250
|
|
Prof Ian H Frazer
|
University of Queensland
|
Determinants of effective
immunotherapy for epithelial tumours
|
2000-2001
|
$344,432
|
|
Prof Ian H Frazer
|
University of Queensland
|
How does papillomavirus
regulate its late gene expression?
|
2000-2001
|
$237,350
|
|
Prof Ian H Frazer
|
University of Queensland
|
Effective immunotherapy for
HPV associated cervical cancer precursor lesions
|
2002-2004
|
$482,640
|
|
Prof Ian H Frazer
|
University of Queensland
|
Immunoregulatory immune
responses to a peripherally presented tumour antigen
|
2003-2005
|
$219,750
|
|
Prof Robert W Tindle
|
University of Queensland
|
Immunological consequences
of epithelial expression of a viral oncoprotein associated with cervical
carcinoma
|
2000-2001
|
$192,069
|
|
Prof Robert W Tindle
|
University of Queensland
|
A cervical cancer vaccine
for the out-bred human population
|
2001-2002
|
$214,697
|
|
Prof Robert W Tindle
|
University of Queensland
|
Overcoming immune response
non-reactivity in cervical cancer
|
2001-2004
|
$212,037
|
|
Prof Robert W Tindle
|
University of Queensland
|
Improving the efficiency of
DNA vaccines
|
2005-2006
|
$182,000
|
|
A/Pr Christine L Clarke
|
University of Sydney
|
Modulation of cytoskeletal
structure by progesterone receptor isoforms
|
2002-2004
|
$337,650
|
|
A/Pr Paul R Harnett
|
University of Sydney
|
Certain death in uncertain
time: a qualitative study of the experience of advanced ovarian cancer
|
2006-2008
|
$217,500
|
|
|
|
|
TOTAL
|
$20,695,736
|
|
Researcher
|
Institution
|
Project Title
|
Duration
|
Total Funding
|
|
Ms Fiona J Bruinsma
|
La Trobe University
|
Perinatal outcomes
following treatment for cervical dysplasia
|
2005-2008
|
$52,121
|
|
Ms Kathryn A Morris
|
La Trobe University
|
Cancer screening: Is there
a coherent ethical framework?
|
2001-2004
|
$86,715
|
|
Dr Simon Chu
|
Prince Henry's Institute of
Medical Research
|
Molecular pathogenesis of
ovarian tumours
|
2000-2003
|
$66,376
|
|
Dr Catherine M Olsen
|
Queensland Institute of
Medical Research
|
Anthropometric indices,
physical activity and ovarian cancer: causation, diagnosis and survival
|
2006-2008
|
$63,693
|
|
Dr Stephen A Myers
|
Queensland University of Technology
|
Estrogen and progesterone
regulation of tissue kalli- krein gene expression in endometrial cancer cell
lines
|
2000-2002
|
$56,627
|
|
Dr Sally E Baron-Hay
|
Royal North Shore Hospital
|
The Role of the
Insulin-like Growth factors and their Binding Proteins in the Pathogenesis of
Ovarian Cancer
|
2001-2004
|
$55,941
|
|
Miss Natalie Wray
|
University of Melbourne
|
Gynaecological Cancers: A
study of the attitudes and experiences of Australian-born and immigrant
Middle Eastern women
|
2001-2003
|
$47,805
|
|
Miss Natalie Wray
|
University of Melbourne
|
The attitudes and
understandings of women with gynaecological cancer.
|
2002
|
$8,900
|
|
Miss Wen Qiu
|
University of Melbourne
|
Cellular, molecular &
genetic characterization of breast & ovarian cancer-associated
fibroblasts (CAFs)
|
2006-2009
|
$63,693
|
|
Miss Chin-Yi Kan
|
University of New South
Wales
|
Investigating the
regions/functions of HPV E6 proteins required for immortalisation of normal
cells
|
2005
|
$20,484
|
|
A/Pr Sherry Wu
|
University of Queensland
|
Liposomal delivery of RNA
inhibitory nucleotides for treatment of cervical cancer
|
2006-2008
|
$80,451
|
|
Dr Jennifer Broom
|
University of Queensland
|
Optimising immunotherapy
for chronic viral infection
|
2006-2008
|
$91,800
|
|
Dr Elizabeth Davey
|
University of Sydney
|
How the prevention of
cervical cancer can be improved by new methods of screening and testing
|
2004-2005
|
$51,897
|
|
Dr Georgina E Hale
|
University of Sydney
|
The natural history of the
physiological, hormonal, endometrial and ovarian dynamics during the
perimenopause: A 3-yr lo
|
2001-2004
|
$98,103
|
|
Dr Rohini Sharma
|
University of Sydney
|
Identification of novel
molecular targets for antibody-directed therapy of ovarian cancer
|
2004-2006
|
$89,517
|
|
Mr Anthony Newall
|
University of Sydney
|
A model for evidence based
introduction of a new vaccine to Australia - human papillomavirus vaccine
|
2006-2007
|
$42,462
|
|
|
|
|
TOTAL
|
$976,585
|